Myasthenia gravis in ceará, Brazil clinical and epidemiological aspects;Miastenia gravis no ceará, Brasil: Aspectos clínicos e epidemiológicos

Arquivos de Neuro-Psiquiatria

Volumn 68, Issue 6, 2010, Pages 843-848

  de Almeida Xavier Aguiar, Aline ^a   Carvalho, André Ferrer ^b   de Castro Costa, Carlos Mauricio ^b   Fernandes, José Marcelino Aragão ^b   D'Almeida, José Artur Costa ^c   de Arruda Furtado, Luís Edmundo Teixeira ^b   da Cunha, Francisco Marcos Bezerra ^b  

^a Hospital Sao Marcos   (Brazil)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^c Hospital Neurology Service   (Brazil)

Author keywords

Clinical evaluation; Epidemiology; Myasthenia gravis

Indexed keywords

AZATHIOPRINE; CHOLINERGIC RECEPTOR ANTIBODY; CORTICOSTEROID; CYCLOSPORIN; IMMUNOGLOBULIN; METHOTREXATE; PYRIDOSTIGMINE;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BRAZIL; CONTROLLED STUDY; DIPLOPIA; DISEASE DURATION; FEMALE; HUMAN; LIMB WEAKNESS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MUSCLE ATROPHY; MUSCLE HYPOTONIA; MYASTHENIA; MYASTHENIA GRAVIS; OCULAR MYASTHENIA; ONSET AGE; PLASMAPHERESIS; PTOSIS; RETROSPECTIVE STUDY; SYMPTOM; THYMECTOMY; THYMOMA;

EID: 79251537196     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2010000600003     Document Type: Article

References (30)

1. Meriggioli MN, Sanders DB. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 2009;8:475-490.
2. Tzartos SJ, Barkas T, Cung MT, et al. Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor. Immunol Rev 1998;163:89-120.
3. Singhal BS, Bhatia NS, Umesh T, Menon S. Myasthenia gravis: a study from India. Neurol India 2008;56: 352-355.
4. Drachman DB. Myasthenia gravis. N Engl J Med 1994;330:1797- 1810.
5. Cunha FM, Scola RH, Werneck LC. Myasthenia gravis: clinical evaluation of 153 patients. Arq Neuropsiquiatr 1999;57:457-464.
6. Sanchez JL, Uribe CS, Franco AF, Jimenez ME, Arcos-Burgos OM, Palacio LG. Prevalence of myasthenia gravis in Antioquia, Colombia. Rev Neurol 2002; 34:1010-1012.
7. Hantai D, Richard P, Koenig J, Eymard B. Congenital myasthenic syndromes. Curr Opin Neurol 2004;17:539-551.
8. Oosterhuis HJ. The natural course of myasthenia gravis: a long term follow up study. J Neurol Neurosurg Psychiatry 1989;52:1121-1127.
9. Heckmann JM, Owen EP, Little F. Myasthenia gravis in South Africans: racial differences in clinical manifestations. Neuromuscul Disord 2007;17:929-934.
10. Alshekhlee A, Miles JD, Katirji B, Preston DC, Kaminski HJ. Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals. Neurology 2009;72:1548-1554.
11. Phillips LH, Torner JC. Epidemiologic evidence for a changing natural history of myasthenia gravis. Neurology 1996;47:1233-1238.
12. Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997;84:223-243.
13. Evoli A, Batocchi AP, Bartoccioni E, Lino MM, Minisci C, Tonali P. Juvenile myasthenia gravis with prepubertal onset. Neuromuscul Disord 1998;8:561-567.
14. Morita MP, Gabbai AA, Oliveira AS, Penn AS. Myasthenia gravis in children: analysis of 18 patients. Arq Neuropsiquiatr 2001;59:681-685.
15. Andrews PI, Massey JM, Sanders DB. Acetylcholine receptor antibodies in juvenile myasthenia gravis. Neurology 1993;43:977-982.
16. De Assis JL, Zambon AA, Souza PS, Marchiori PE. Myasthenia gravis and thymoma. Evaluation of 41 patients. Arq Neuropsiquiatr 1999;57:6-13.
17. Robertson NP, Deans J, Compston DA. Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England. J Neurol Neurosurg Psychiatry 1998;65:492-496.
18. Osserman KE, Genkins G. Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients. Mt Sinai J Med 1971;38:497-537.
19. Christensen PB, Jensen TS, Tsiropoulos I, et al. Incidence and prevalence of myasthenia gravis in western Denmark: 1975 to 1989. Neurology 1993;43: 1779-1783.
20. Thanvi BR, Lo TC. Update on myasthenia gravis. Postgrad Med J 2004;80:690-700.
21. Aragones JM, Bolibar I, Bonfill X, et al. Myasthenia gravis: a higher than expected incidence in the elderly. Neurology 2003;60:1024-1026.
22. Vincent A, Clover L, Buckley C, Grimley Evans J, Rothwell PM. Evidence of underdiagnosis of myasthenia gravis in older people. J Neurol Neurosurg Psychiatry 2003;74:1105-1108.
23. Phillips LH. The epidemiology of myasthenia gravis. Ann N Y Acad Sci 2003; 998:407-412.
24. Conti-Fine BM, Milani M, Kaminski HJ. Myasthenia gravis: past, present, and future. J Clin Invest 2006;116:2843-2854.
25. Oh SJ, Kim DE, Kuruoglu R, Bradley RJ, Dwyer D. Diagnostic sensitivity of the laboratory tests in myasthenia gravis. Muscle Nerve 1992;15:720-724.
26. Phillips LH, Melnick PA. Diagnosis of myasthenia gravis in the 1990s. Semin Neurol 1990;10:62-69.
27. Rowland LP. Controversies about the treatment of myasthenia gravis. J Neurol Neurosurg Psychiatry 1980;43:644-659.
28. Werneck LC, Cunha FM, Scola RH. Myasthenia gravis: a retrospective study comparing thymectomy to conservative treatment. Acta Neurol Scand 2000; 101:41-46.
29. Tsinzerling N, Lefvert AK, Matell G, Pirskanen-Matell R. Myasthenia Gravis: a long term follow-up study of Swedish patients with specific reference to thymic histology. J Neurol Neurosurg Psychiatry 2007;78:1109-1112.
30. Lavrnic D, Jarebinski M, Rakocevic-Stojanovic V, et al. Epidemiological and clinical characteristics of myasthenia gravis in Belgrade, Yugoslavia (1983-1992). Acta Neurol Scand 1999;100:168-174.